News

Ublituximab bests teriflunomide in head-to-head clinical trials
- Author:
- Kate Johnson
Publish date: August 30, 2022
News

VTE risk not elevated in AD patients on JAK inhibitors: Study
- Author:
- Kate Johnson
Publish date: August 30, 2022
News
‘Flat denial’ can leave breast cancer patients with lasting scars
- Author:
- Kate Johnson
Publish date: August 26, 2022
News
Underweight in early childhood persists
- Author:
- Kate Johnson
Publish date: August 8, 2022
News
Injectable HIV prevention better than pills in two trials
- Author:
- Kate Johnson
Publish date: August 2, 2022
News
Landmark ALLIANCE results offer tenofovir guidance in HIV/HBV coinfection
- Author:
- Kate Johnson
Publish date: August 2, 2022
News
Doxycycline cuts STI risk in men and trans women having sex with men
- Author:
- Kate Johnson
Publish date: July 29, 2022
News
Prolonged remission in patient with HIV may open new avenues to functional cure
- Author:
- Kate Johnson
Publish date: July 29, 2022
News
Fourth patient cleared of HIV after stem cell transplant for blood cancer
- Author:
- Kate Johnson
Publish date: July 28, 2022
News
CAR T-cell therapy turns 10 and finally earns the word ‘cure’
- Author:
- Kate Johnson
Publish date: July 22, 2022
News
Tofersen linked to slow, positive effects in ALS
- Author:
- Kate Johnson
Publish date: June 23, 2022
News
My choice? Unvaccinated pose outsize risk to vaccinated
- Author:
- Kate Johnson
Publish date: May 10, 2022
News
Drug combo holds promise as on-demand contraceptive: Study
- Author:
- Kate Johnson
Publish date: May 2, 2022
News
Three symptoms suggest higher risk for self-injury in cancer
- Author:
- Kate Johnson
Publish date: April 29, 2022
News
Age and ferritin levels may predict MIS-C severity
- Author:
- Kate Johnson
Publish date: April 19, 2022